Blood pressure medicine recalled due to traces of cancer-causing impurity

National and World
Blood pressure generic

The Food and Drug Administration is warning consumers about a blood pressure medication recall.

Some losartan potassium hydrochlorothiazide (also known as Losartan) tablets have been recalled due to a trace of a potentially cancer-causing impurity.

The recall affects losartan potassium hydrochlorothiazide  100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, lot number JB8912 with an expiration date of 06/2020.

The medication was distributed around the country after October 8, 2018.

The International Agency for Research on Cancer has classified N- nitrosodiethylamine as a probable human carcinogen.

The impurity is found naturally in certain foods, drinking water, air pollution and industrial processes.

Sandoz Inc., the drug manufacturer, hasn’t heard of anyone getting sick because of it.

Patients with questions can call Sandoz Inc. at 1-800-525-8747 Monday through Friday from 8:30 a.m. to 5 p.m. You can also email the company at usdrugsafety.operations@novartis.com.

Patients should contact their doctor or pharmacist about an alternative medication to take in the meantime or if they experienced problems while taking the recalled medication.

Any bad reactions or problems with this medication can be reported to the FDA through an online form.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending on WKBN.com